Vimarsana
Biggest News Aggregation in the World

Page 49 - Research Square News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Square Today - Breaking & Trending Today

Phylogenomic characterization of the first genome sequences of the monkeypox virus outbreak variant - Vimarsana News

Phylogenomic characterization of the first genome sequences of the monkeypox virus outbreak variant

Researchers characterized infections caused by the monkeypox virus (MPXV).

Pfizer antiviral found to cut COVID risk in seniors irrespective of vaccination (NYSE:PFE) - Vimarsana News

Pfizer antiviral found to cut COVID risk in seniors irrespective of vaccination (NYSE:PFE)

A new study has indicated that Pfizer’s (PFE) COVID-19 pill Paxlovid could reduce hospitalization and death rates in COVID-19 patients aged 65 years and older regardless of...

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge - Vimarsana News

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge

Researchers evaluated how effective nirmatrelvir is in preventing COVID-19-associated death and hospitalization in high-risk patients.

Presence of monkeypox viruses in distantly associated small mammal species - Vimarsana News

Presence of monkeypox viruses in distantly associated small mammal species

A recent study depicted that distantly linked tiny mammal species from the Democratic Republic of the Congo harbor monkeypox viruses (MPXV).

Paxlovid reduces COVID risk in seniors regardless of vax status: Study - Vimarsana News

Paxlovid reduces COVID risk in seniors regardless of vax status: Study

Pfizer's Paxlovid reduces COVID-19 hospitalization and death rates in patients 65 years and older, saida new study.

Source: canada.com